Dr. Kurt Denninghoff MedPage Today interview on hormone therapy for TBI clinical trial
"No one was sadder than I was when I heard that the drug wasn't showing a benefit," said Kurt Denninghoff, MD, of the University of Arizona, who served as "hub principal investigator" at one of the 21 sites in the trial. Read more:
Hormone Therapy Fails in TBI Trials
Flawed Outcome Measures May Explain Failed TBI Studies
